KZIA Latest Press Releases

-- May 26, 2026 --

Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer PRNewswire 7:30 AM

-- April 15, 2026 --

Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform PRNewswire 8:00 AM

-- January 30, 2026 --

Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2) PRNewswire 8:00 AM

-- January 27, 2026 --

Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer PRNewswire 8:00 AM

-- January 8, 2026 --

Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End PRNewswire 9:01 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software